MedTrace Logo

Innsbruck Health Promotion Program

NCT06813677 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-11-19

No results posted yet for this study

Summary

The primary goal of this single-centre. single-arm, unblinded, pre-post interventional study is to evaluate whether a one-time health assessment and intervention affects the overall vascular health evaluated through the Life's Essential 8 overall vascular health score.

Secondary goals of this study are, among others:

* to describe incidence and prevalence of vascular risk-factors and behaviours
* to explore prevalence and associations of health and disease in the general population with special focus on cardiovascular risk, cardiovascular diseases, markers of vascular health, signs and (prodromal) symptoms of neurodegeneration as well as psychosocial factors
* to explore the prevalence of hearing disorders in the general population
* to collect voice and speech samples to identify novel biomarkers that correlate to vascular health and/or hearing status

Conditions

  • Assessment of Vascular Health Risk Factors

Interventions

OTHER

In-person health promotion

The results from the initial pre-baseline examination are reviewed during the baseline visit to identify potential risk factors related to the Life's Essential 8 (LE8). Based on these findings, participants receive personalized recommendations to enhance their vascular health and information on local vascular health promotion resources. Additionally, participants receive bi-monthly motivational newsletters designed to support ongoing vascular health improvements.

Sponsors & Collaborators

  • Oroboros Instruments

    collaborator UNKNOWN

  • Med-El Corporation

    collaborator INDUSTRY

  • Tirol Kiniken GmbH

    collaborator OTHER

  • Österreichische Gesundheitskasse

    collaborator UNKNOWN

  • VASCage GmbH

    lead OTHER

Principal Investigators

  • Dr.med. Lukas Mayer-Süß, PhD · Medical University of Innsbruck

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2027-01-31
Completion
2027-03-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06813677 on ClinicalTrials.gov